Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples